Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yuhuai Hu"'
Autor:
Hao Yan, Wentong Wu, Yuhuai Hu, Jinjin Li, Jiangxin Xu, Xueqin Chen, Zhifei Xu, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-20 (2023)
Abstract The hepatotoxicity of regorafenib is one of the most noteworthy concerns for patients, however the mechanism is poorly understood. Hence, there is a lack of effective intervention strategies. Here, by comparing the target with sorafenib, we
Externí odkaz:
https://doaj.org/article/9c865dd403c243cd8eab4ad027981d2c
Autor:
Hao Yan, Wentong Wu, Yuhuai Hu, Jinjin Li, Xueqin Chen, Zhifei Xu, Bo Yang, Qiaojun He, Peihua Luo
Hepatotoxicity of regorafenib is one of the most noteworthy concerns for patients, however the mechanism has poorly understood. Hence, lack of effective intervention strategy. In this study, we found that regorafenib-induced liver injury mainly deriv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::769bdc56618d70d59055ee0b67e01b4b
https://doi.org/10.21203/rs.3.rs-2159741/v1
https://doi.org/10.21203/rs.3.rs-2159741/v1
Autor:
Zizheng Gao, Yuhuai Hu, Huangxi Fu, Feng Jiang, Hao Yan, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo, Zhifei Xu
Publikováno v:
Toxicology letters. 373
Dasatinib, a second-generation BCR-ABL inhibitor, is currently used as first-line treatment for patients with chronic myeloid leukemia. However, dasatinib treatment increases the risk of severe cutaneous toxicity, which limits its long-term safe use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7adb8fce3ae510bf2f4de00722ae5742
https://pubmed.ncbi.nlm.nih.gov/36375637
https://pubmed.ncbi.nlm.nih.gov/36375637
Autor:
Xiaochun Yang, Yuhuai Hu, Ziying Zhao, Ziye Zhou, Xiaochen Zhang, Peihua Luo, Bo Yang, Xueqin Chen, Qiaojun He
Publikováno v:
Toxicology Letters. 319:102-110
Crizotinib is a multi-target receptor tyrosine kinase inhibitor which is of great importance for the management of ALK-rearranged non-small cell lung cancer (NSCLC) patients. Serious erythroderma and toxic epidermal necrolysis have been reported asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d3a58e86f3229943cccbb61beed3ec4
https://doi.org/10.1016/j.toxlet.2019.11.007
https://doi.org/10.1016/j.toxlet.2019.11.007
Autor:
Lianbin Xia, Hao Zhou, Jinkai Chen, Fuhai Liu, Shiyuan Chang, Yuhuai Huang, Jingyang Jiang, Kang Dong, Yun Wu, Chenhao Zhang, Weipeng Xuan, Shurong Dong, Jikui Luo
Publikováno v:
Advanced Electronic Materials, Vol 10, Iss 6, Pp n/a-n/a (2024)
Abstract Triboelectric nanogenerator (TENG) is a promising technology, which can convert biokinetic energy into electricity and be utilized as self‐powered sensors and power sources for wearable electronics. The existing designs of conventional TEN
Externí odkaz:
https://doaj.org/article/0244f3f9b4744f448d7eb0d96aa00137
Publikováno v:
European journal of pharmacology. 874
Glioma is a kind of lethal malignant tumor, and lacks efficient therapies. Combination therapy has been claimed to be a promising approach to combat cancer, due to its increased anti-cancer effects and reduced side effects. This study aimed to invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1667d58582125f52fe82cfe84c9e604e
https://pubmed.ncbi.nlm.nih.gov/32084420
https://pubmed.ncbi.nlm.nih.gov/32084420
Publikováno v:
Biochemical Pharmacology. 185:114407
The tumor suppressor protein p53 participates in the control of key biological functions such as cell death, metabolic homeostasis and immune function, which are closely related to various diseases such as tumors, metabolic disorders, infection and n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c16dac23b07876f68d3eb1501017ac4
https://doi.org/10.1016/j.bcp.2021.114407
https://doi.org/10.1016/j.bcp.2021.114407
PRISMA 2009 checklist. (DOC 63 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85652d78306f225264da954c750dcfc2
PRISMA 2009 flow diagram. (DOC 60 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d23e5d4062a47cee65af143e548428
Publikováno v:
BMC Anesthesiology
Background The management of neuropathic pain (NP) is challenging despite it being the recent focus of extensive research. A number of clinical practice guidelines (CPGs) for the management of NP have been published worldwide over the past 2 decades.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a98830536dd359c277ddaa165cba740
https://pubmed.ncbi.nlm.nih.gov/26892406
https://pubmed.ncbi.nlm.nih.gov/26892406